{
    "organizations": [],
    "uuid": "31cdda1bfa5558cc15dcc03e761bf11aad7f62ec",
    "author": "Peter Loftus",
    "url": "https://www.wsj.com/articles/trial-tests-ftcs-power-to-referee-drug-makers-fight-against-generics-1519131601",
    "ord_in_thread": 0,
    "title": "Trial Tests FTC’s Power to Referee Drug Makers’ Fight Against Generics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "A trial under way in federal court in Philadelphia is testing the power of U.S. competition regulators to crack down on drugmakers’ alleged moves to thwart the sale of low-cost generics.\nThe trial, which began Feb. 7, stems from a 2014 Federal Trade Commission lawsuit accusing AbbVie Inc. of filing baseless patent-infringement lawsuits against two generic-drug companies to delay competition for its testosterone-replacement therapy AndroGel. AbbVie denies the allegations.\n...  ",
    "published": "2018-02-20T15:00:00.000+02:00",
    "crawled": "2018-02-20T23:11:46.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "trial",
        "way",
        "federal",
        "court",
        "philadelphia",
        "testing",
        "power",
        "competition",
        "regulator",
        "crack",
        "drugmakers",
        "alleged",
        "move",
        "thwart",
        "sale",
        "generic",
        "trial",
        "began",
        "stem",
        "federal",
        "trade",
        "commission",
        "lawsuit",
        "accusing",
        "abbvie",
        "filing",
        "baseless",
        "lawsuit",
        "two",
        "company",
        "delay",
        "competition",
        "therapy",
        "androgel",
        "abbvie",
        "denies",
        "allegation"
    ]
}